| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |